A groundbreaking vaccine to protect infants from severe respiratory syncytial virus (RSV) is now available in South Africa’s private healthcare sector. Still, a decision on its inclusion in the public programme remains pending. The country’s National Advisory Group on Immunisation (NAGI) has formally recommended the RSV infant vaccine for all pregnant women. They have left the final decision to the…